| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 526,816 | 532,142 | 537,956 | 547,392 | | Cost of Revenue | (119,887) | (33,664) | 153,551 | 54,988 | | | Gross Profit | 646,703 | 565,806 | 384,405 | 492,404 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 356,633 | 296,372 | 107,337 | 201,655 | | Non Recurring | 14,457 |
-
|
-
|
-
| | Others | 103,123 | 132,818 | 137,558 | 138,815 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 172,490 | 136,616 | 139,510 | 151,934 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,855 | 4,892 | 7,973 | 2,874 | | Earnings Before Interest And Taxes | 178,345 | 141,234 | 147,757 | 154,808 | | Interest Expense | 96,578 | 98,670 | 88,749 | 90,731 | | Income Before Tax | 81,767 | 42,564 | 59,008 | 64,077 | | Income Tax Expense | 29,021 | 14,254 | 22,053 | 29,779 | | Minority Interest | (1,631) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 51,115 | 28,310 | 36,955 | 34,298 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 51,115 | 28,310 | 36,955 | 34,298 | | Preferred Stock And Other Adjustments | 1,044 | (392) | (652) |
-
| | | Net Income Applicable To Common Shares | $52,159 | $27,918 | $36,303 | $34,298 |
|
0.02% Nasdaq 0.00%
Income Statement
